Structure and function of the CD7 molecule

被引:2
|
作者
Sempowski, GD
Lee, DM
Kaufman, RE
Haynes, BF
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Rheumatol Allergy & Clin Immunol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Hematol Oncol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA
关键词
T cells; NK cells; leukemia; septic shock;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD7 is a single-domain Ig superfamily molecule expressed on human T and NK cells, as well as on cells in the early stages of T, B, and myeloid cell differentiation. CD7 is highly expressed on malignant immature T cells and is generally absent on malignant mature T cells, such as CD4(+) Sezary leukemia and HTLV-1(+) adult T-cell leukemia cells. Because of lack of identification of a natural ligand and lack of a monoclonal antibody against murine CD7, the in vivo functions of CD7 have until recently remained obscure. Recent studies in CD7-deficient mice have provided new insights into CD7 function, and demonstrated key roles for CD7 in regulating peripheral T and NK cell cytokine production and sensitivity to LPS-induced shock syndromes. This article reviews recent work on the expression, structure, and function of CD7, and discusses roles the CD7 molecule might play in T and NK cell development and function.
引用
收藏
页码:331 / 348
页数:18
相关论文
共 50 条
  • [1] EXPRESSION AND FUNCTION OF CD7 MOLECULE ON HUMAN NATURAL-KILLER-CELLS
    RABINOWICH, H
    PRICOP, L
    HERBERMAN, RB
    WHITESIDE, TL
    JOURNAL OF IMMUNOLOGY, 1994, 152 (02): : 517 - 526
  • [2] CHARACTERIZATION OF THE SURFACE-TOPOGRAPHY AND PUTATIVE TERTIARY STRUCTURE OF THE HUMAN CD7 MOLECULE
    WARE, RE
    SCEARCE, RM
    DIETZ, MA
    STARMER, CF
    PALKER, TJ
    HAYNES, BF
    JOURNAL OF IMMUNOLOGY, 1989, 143 (11): : 3632 - 3640
  • [3] CD7 - A REVIEW
    CHANG, KL
    WEISS, LM
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 146 - 156
  • [4] NATURE OF CD7 LIGAND AS SUGGESTED BY THE INTERACTION BETWEEN RECOMBINANT CD7 AND CONCANAVALIN-A
    OSSOWSKI, E
    JUNG, LKL
    CLINICAL RESEARCH, 1994, 42 (02): : A309 - A309
  • [5] Interaction between the extracellular domain of CD7 and concanavalin A: A clue to the identity of the ligand for CD7
    Leta, E
    Hou, ZC
    Lederman, L
    Jung, LK
    CELLULAR IMMUNOLOGY, 1996, 173 (01) : 15 - 21
  • [6] Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia
    Freiwan, Abdullah
    Vaidya, Abishek
    Zebley, Caitlin
    Fan, Yiping
    Langfitt, Deanna
    Youngblood, Benjamin
    Mamonkin, Maksim
    Gottschalk, Stephen
    Velasquez, Mireya Paulina
    BLOOD, 2019, 134
  • [7] Targeting AML with Naturally Occurring CD7 Negative T Cells Expressing CD7 CAR
    Thanekar, Unmesha
    Nevitt, Chris
    Zoine, Jaquelyn T.
    Mamonkin, Maksim
    Umeda, Masayuki
    Klco, Jeffery
    Velasquez, M. Paulina
    MOLECULAR THERAPY, 2024, 32 (04) : 121 - 122
  • [8] Initial characterization of CD7 deficient mice: Evidence of a role for CD7 in regulation of thymocyte development
    Lee, DM
    Sundy, JS
    Staats, HF
    Patel, DD
    Haynes, BF
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A219 - A219
  • [9] CD7 CAR: sword and shield
    Velasquez, M. Paulina
    Mamonkin, Maksim
    BLOOD, 2022, 140 (04) : 293 - 294
  • [10] CD7 EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA
    HIBI, S
    KATAOKA, Y
    FUJITA, N
    OKABE, H
    YOSHIKAWA, K
    SETO, M
    UEDA, R
    IMASHUKU, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (07): : 680 - 683